ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

High Risk workshop Planned To Produce Monograph On Current Knowledge

October 11, 1974

NCAB Criticizes Coverage’ Of NCI Screening Statement

March 4, 1994

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

CCOPs Payline Set In Low 220s Fr Now; 45 To Be Funded

May 15, 1987

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000